{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:49:40Z","timestamp":1791910180484,"version":"4.3.4"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Galderma R&D"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rosacea is a chronic facial disease that may lead to feelings of stigmatization, which can negatively impact psychological and social well\u2010being.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate different aspects of rosacea that could contribute to feelings of stigmatization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online survey of a representative sample of the adult population in the UK, France, Germany and US was conducted to identify patients with rosacea based on presence of three or more clinical features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the patients who completed the survey (\n                      <jats:italic>n<\/jats:italic>\n                      = 807), mean age at first sign\/symptom of rosacea was 31.3 \u00b1 14.5 years; mean duration of disease was 102 \u00b1 119 months. One\u2010third of patients reported feelings of stigmatization (FS;\n                      <jats:italic>n<\/jats:italic>\n                      = 275). Male patients were more likely to experience FS (49% vs. 37.2% in non\u2010FS population;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0037). Those with FS were more likely to avoid social situations (54.2% vs. 2.0%,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 1.00\n                      <jats:sup>E\u201010<\/jats:sup>\n                      ) and had a higher rate of depression (36.7% vs. 21.1%,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 1.00\n                      <jats:sup>E\u201010<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Stigmatization is important in the daily lives of those with rosacea and should be taken into consideration in the management of these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.13748","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T03:03:05Z","timestamp":1466478185000},"page":"163-168","source":"Crossref","is-referenced-by-count":88,"title":["Feelings of stigmatization in patients with rosacea"],"prefix":"10.1111","volume":"31","author":[{"given":"B.","family":"Halioua","sequence":"first","affiliation":[{"name":"Institut Alfred Fournier Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cribier","sequence":"additional","affiliation":[{"name":"Clinique Dermatologique Universit\u00e9 de Strasbourg et H\u00f4pitaux Universitaires de Strasbourg Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Psychology University of Windsor Windsor ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tan","sequence":"additional","affiliation":[{"name":"University of Western Ontario and Windsor Clinical Research Inc Windsor ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.04.043"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04549.x"},{"key":"e_1_2_7_4_1","first-page":"1","article-title":"Psychosocial implications of rosacea","author":"Baldwin HE","year":"2012","journal-title":"Dermatologist"},{"key":"e_1_2_7_5_1","first-page":"38","article-title":"Rosacea: a review","volume":"34","author":"Culp B","year":"2009","journal-title":"P T"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2006.05017.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09894.x"},{"key":"e_1_2_7_8_1","first-page":"385","article-title":"Quality of life in patients with rosacea","volume":"65","author":"Salamon M","year":"2008","journal-title":"Przegl Lek"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170902741311"},{"key":"e_1_2_7_10_1","first-page":"997","article-title":"Psychosocial impact of rosacea","volume":"64","author":"Chodkiewicz J","year":"2007","journal-title":"Przegl Lek"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1087-0024.2004.09113.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.04.010"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(84)90050-6"},{"key":"e_1_2_7_14_1","first-page":"99","article-title":"Psychological disorders associated with rosacea: analysis of unscripted comments","volume":"19","author":"Cardwell L","year":"2015","journal-title":"JSSDDS"},{"key":"e_1_2_7_15_1","first-page":"73","article-title":"The CLEAR trial: results of a large community\u2010based study of metronidazole gel in rosacea","volume":"79","author":"Wolf JE","year":"2007","journal-title":"Cutis"},{"key":"e_1_2_7_16_1","unstructured":"National Rosacea Society.Coping with Rosacea. Tips on Lifestyle Management for Rosacea Sufferers: National Rosacea Society. [WWW document]1996. URLhttp:\/\/www.rosacea.org\/patients\/materials\/coping\/index.php(last accessed: 07 June 2016)."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-015-0077-2"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70007-4"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1193"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/000155599750009870"},{"key":"e_1_2_7_21_1","first-page":"2773","article-title":"Acne vulgaris: the pyschosocial and psychological burden of illness","volume":"21","author":"Fried RG","year":"2013","journal-title":"Dermatologist"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000084751"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01897.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000082564"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01216.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2002.00071.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1995.tb04656.x"},{"key":"e_1_2_7_28_1","first-page":"16","article-title":"Oral therapy for rosacea","volume":"5","author":"Baldwin HE","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_7_29_1","first-page":"435","article-title":"Rosacea: a common, yet commonly overlooked, condition","volume":"66","author":"Blount BW","year":"2002","journal-title":"Am Fam Physician"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.763"},{"key":"e_1_2_7_31_1","unstructured":"National Rosacea Society.What is rosacea?[WWW document] 2015. URLwww.rosacea.org.index.php(last accessed: 07 June 2016)."},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06895.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13748","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13748","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T10:31:03Z","timestamp":1694860263000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.13748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,21]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1111\/jdv.13748"],"URL":"https:\/\/doi.org\/10.1111\/jdv.13748","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726439099.793552702","asserted-by":"object"}]},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,21]]}}}